COMPANY PROFILE · UPDATED 18 NOV 2025

SiteOne Therapeutics

SiteOne Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of hypersensitivity disorders such as chronic cough, itch, and pain.

siteonetherapeutics.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2014
Headcount: 30
Open roles: 0
Last raised: Series C · Sign in to view

LEADERSHIP

Founders & key people

OPEN ROLES

Roles at SiteOne Therapeutics

Employbl doesn’t track SiteOne Therapeutics’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →

FUNDING

Capital raised

Total raised

$134,178,360

Investors

2MAmgenBSQUARED CapitalBay CapitalBioBritJoe ZakrzewskiMission Bay CapitalMission BioCapitalNational Institute on Drug Abuse (NIDA)Next Frontier CapitalNovo HoldingsOrbiMed AdvisorsSears Capital ManagementWellington ManagementZ Investments

Funding rounds

Series C
Novo Holdings, BSQUARED Capital, OrbiMed Advisors, Mission BioCapital, Wellington Management
$100MDec 17, 2024
Grant
National Institute on Drug Abuse (NIDA)
$15MMay 17, 2023
Series B
Amgen, Next Frontier Capital, 2M, Mission Bay Capital, Sears Capital Management, Z Investments, BioBrit, Mission BioCapital
$15MJan 5, 2017
Series Unknown
Next Frontier Capital, Sears Capital Management, Mission Bay Capital, BioBrit
$1.3MJul 14, 2015
Series A
Sears Capital Management, Bay Capital, BioBrit, Joe Zakrzewski
$1.5MSep 23, 2014
Grant
$1.4MSep 22, 2014

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Industries

Medical Organizations Health Care Companies Biotechnology Companies

LOCATIONS

Where they work

SiteOne Therapeutics offices

Loading map…

Bozeman, MT960 Technology Boulevard